25-Aug-2022 | S | Ajooni Biotech Limited has informed the Exchange about Board Meeting held on 25-Aug-2022 to consider Split of shares and Other business matters.
Ajooni Biotech Limited has informed the Exchange about Split of shares.
(As Per NSE Announcement Dated on 21.09.2022)
Ajooni Biotech Limited has informed the Exchange that Record date for the purpose of Split/Subdivision is 07-Oct-2022.
(As Per NSE Announcement Dated on 22.09.2022)
Ajooni Biotech Limited has informed the Exchange about Newspaper Advertisements of Intimation of Record Date for sub-division of equity shares.
(As Per NSE Announcement Dated on 24.09.2022)
Sub: Change in ISIN - Ajooni Biotech Limited (AJOONI)
Members of the Exchange are hereby informed that the ISIN Code for the equity shares of the following company shall be changed w.e.f. October 07, 2022.
Symbol
AJOONI
Company Name
Ajooni Biotech Limited
New ISIN
INE820Y01021
Remarks
Sub-Division from Rs. 10/- to Rs. 2/-
The new ISIN shall be effective for all trades done on and from the Ex-date date i.e., October 07, 2022.
For and on behalf of
National Stock Exchange of India Limited
(As Per NSE Circular Dated on 30.09.2022) | 07-Oct-2022 | |
02-Mar-2021 | B | 1:9 Bonus Issue of Equity Shares | 12-Mar-2021 | 1:9 |
26-Apr-2024 | R | Rights issue of Equity Shares 1:1 @ Premium Rs 3/- | 02-May-2024 | 1:1 |
23-Nov-2022 | R | 29:30 Rights Issue of Equity Shares | 25-Nov-2022 | 29:30 |
22-Mar-2024 | BC | Ajooni Biotech Limited has informed the Exchange that Record date for the purpose of Rights is 01-Apr-2024.
Ajooni Biotech Limited had intimated the 01-Apr-2024 as the record date. The Company ha | 02-May-2024 | |
26-Apr-2024 | BC | Rights issue of Equity Shares 1:1 @ Premium Rs 3/- | 02-May-2024 | |
30-Jan-2024 | BC | To consider and approve the un-audited financial results for the period ended December 31, 2023 and other business matters.
Ajooni Biotech Limited has informed the Exchange regarding Board meetin | 07-Feb-2024 | |
01-Nov-2023 | BC | To consider and approve the financial results for the period ended September 30, 2023
Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on November 09, 2023.
(As Pe | 09-Nov-2023 | |
06-Oct-2023 | BC | To consider Fund Raising
Ajooni Biotech Limited has informed the Exchange regarding the Board meeting held on October 14, 2023, to consider Fundraising through the right issue and other matters.
| 14-Oct-2023 | |
No Dividends has been declared by AJOONI
Record Date12-Mar-2021
Ex-Bonus Date10-Mar-2021
Ratio1:9
Record Date07-Oct-2022
Split Date07-Oct-2022
Face Value (Before/After)10/2
RightsRecord Date01 Jan'1900
Ex-Rights Date01 Jan'1900
Premium(Rs.)3
Ratio1:1
Record Date01 Jan'1900
Ex-Rights Date01 Jan'1900
Premium(Rs.)4
Ratio29:30
Book Closure
02-May-2024 | 01 Jan'1900 | Ajooni Biotech Limited has informed the Exchange that Record date for the purpose of Rights is 01-Apr-2024.
Ajooni Biotech Limited had intimated the 01-Apr-2024 as the record date. The Company ha |
02-May-2024 | - | Rights issue of Equity Shares 1:1 @ Premium Rs 3/- |
07-Feb-2024 | - | To consider and approve the un-audited financial results for the period ended December 31, 2023 and other business matters.
Ajooni Biotech Limited has informed the Exchange regarding Board meetin |
09-Nov-2023 | - | To consider and approve the financial results for the period ended September 30, 2023
Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on November 09, 2023.
(As Pe |
14-Oct-2023 | - | To consider Fund Raising
Ajooni Biotech Limited has informed the Exchange regarding the Board meeting held on October 14, 2023, to consider Fundraising through the right issue and other matters.
|